Prana Surgical’s CEO Wants to Bring a Lumpectomy Approach to Lung Surgery

Surgical robotics consolidation (Stryker-CMR) and antitrust pressure on device giants are reshaping medtech, while startups like Prana target precision lung cancer intervention.

• Stryker-CMR deal: Stryker signed a roughly $400M agreement for U.S. rights to CMR Surgical's Versius Plus soft-tissue robot, with an exclusive option to acquire CMR outright, marking Stryker's entry into soft-tissue surgical robotics against Intuitive and J&J's Ottava.
• Intuitive settles antitrust suit: Intuitive will pay roughly $450M to settle a class action over alleged monopolization of DaVinci repair services, part of a broader wave of antitrust losses hitting Medtronic (Applied Medical suit) and J&J's Biosense Webster ($47M verdict).

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.